Daniel Miller Rotroff

Lewis, A. M., Jr., Thomas, R., Breen, M., Peden, K., Teferedegne, B., Foseh, G., … Lewis, G. (2022). The AGMK1-9T7 cell model of neoplasia: Evolution of DNA copy-number aberrations and miRNA expression during transition from normal to metastatic cancer cells. PLOS ONE, 17(10). https://doi.org/10.1371/journal.pone.0275394

McDonough, C. W., Warren, H. R., Jack, J. R., Motsinger‐Reif, A. A., Armstrong, N. D., Bis, J. C., … Cooper‐DeHoff, R. M. (2021). Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome‐Wide Interaction Meta‐Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies. Clinical Pharmacology & Therapeutics, 110(3), 723–732. https://doi.org/10.1002/cpt.2355

Ash, J. R., Kuenemann, M. A., Rotroff, D., Motsinger-Reif, A., & Fourches, D. (2019). Cheminformatics approach to exploring and modeling trait-associated metabolite profiles. JOURNAL OF CHEMINFORMATICS, 11. https://doi.org/10.1186/s13321-019-0366-3

Morieri, M. L., Gao, H., Pigeyre, M., Shah, H. S., Sjaarda, J., Mendonca, C., … Doria, A. (2018). Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial. DIABETES CARE, 41(11), 2404–2413. https://doi.org/10.2337/dc18-0709

Shahin, M. H., Gong, Y., Frye, R. F., Rotroff, D. M., Beitelshees, A. L., Baillie, R. A., … Johnson, J. A. (2018). Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 7(1). https://doi.org/10.1161/jaha.117.006656

Teferedegne, B., Rotroff, D. M., Macauley, J., Foseh, G., Lewis, G., Motsinger-Rief, A., & Lewis, A. M., Jr. (2017, October 4). Assessment of potential miRNA biomarkers of VERO-cell tumorigenicity in a new line (AGMK1-9T7) of African green monkey kidney cells. VACCINE, Vol. 35, pp. 5503–5509. https://doi.org/10.1016/j.vaccine.2017.04.004

Marvel, S. W., Rotroff, D. M., Wagner, M. J., Buse, J. B., Havener, T. M., McLeod, H. L., & Motsinger-Reif, A. A. (2017). Common and rare genetic markers of lipid variation in subjects with type 2 diabetes from the ACCORD clinical trial. PeerJ, 5.

Rotroff, D. M., Marvel, S. W., Jack, J. R., Havener, T. M., Doria, A., Shah, H. S., … Motsinger-Reif, A. A. (2017). Common genetic variants in neurobeachin (nbea) are associated with metformin drug response in individuals with type 2 diabetes in the accord clinical trial. Clinical Pharmacology & Therapeutics, Vol. 101, pp. S9–9.

St John-Williams, L., Blach, C., Toledo, J. B., Rotroff, D. M., Kim, S., Klavins, K., … Saykin, A. J. (2017). Data descriptor: Targeted metabolomics and medication classification data from participants in the ADNI1 cohort. Scientific Data, 4.

Toledo, J. B., Arnold, M., Kastenmuller, G., Chang, R., Baillie, R. A., Han, X. L., … Motsinger-Reif, A. (2017). Metabolic network failures in Alzheimer's disease: A biochemical road map. Alzheimers & Dementia, 13(9), 965–984.

Nguyen, T. V., Reuter, J. M., Gaikwad, N. W., Rotroff, D. M., Kucera, H. R., Motsinger-Reif, A., … Schmidt, P. J. (2017). The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: Effects of estradiol and progesterone addback. Translational Psychiatry, 7.

Gillis, N. K., Rotroff, D. M., Mesa, T. E., Yao, J. Q., Chen, Z. H., Carulli, M. A., … McLeod, H. L. (2017). Tumor exome sequencing and copy number alterations reveal potential predictors of intrinsic resistance to multi-targeted tyrosine kinase inhibitors. Oncotarget, 8(70), 115114–115127.

Shahin, M. H., Gong, Y., McDonough, C. W., Rotroff, D. M., Beitelshees, A. L., Garrett, T. J., … Kaddurah-Daouk, R. (2016). A genetic response score for hydrochlorothiazide use insights from genomics and metabolomics integration. Hypertension, 68(3), 621-.

Irvin, M. R., Rotroff, D. M., Aslibekyan, S., Zhi, D. G., Hidalgo, B., Motsinger-Reif, A., … Rotter, J. I. (2016). A genome-wide study of lipid response to fenofibrate in Caucasians: A combined analysis of the GOLDN and ACCORD studies. Pharmacogenetics and Genomics, 26(7), 324–333.

Judson, R., Houck, K., Martin, M., Richard, A. M., Knudsen, T. B., Shah, I., … Huang, R. L. (2016). Analysis of the effects of cell stress and cytotoxicity on in vitro assay activity across a diverse chemical and assay space. Toxicological Sciences, 152(2), 323–339.

Roode, S. C., Rotroff, D., Richards, K. L., Moore, P., Motsinger-Reif, A., Okamura, Y., … Breen, M. (2016). Comprehensive genomic characterization of five canine lymphoid tumor cell lines. BMC Veterinary Research, 12.

Rotroff, D. M., & Motsinger-Reif, A. A. (2016). [Review of Embracing integrative multiomics approaches]. International Journal of Genomics.

Graham, H. T., Rotroff, D. M., Marvel, S. W., Buse, J. B., Havener, T. M., Wilson, A. G., … Motsinger-Reif, A. A. (2016). Incorporating concomitant medications into genome-wide analyses for the study of complex disease and drug response. Frontiers in Genetics, 7.

Rotroff, D. M., Joubert, B. R., Marvel, S. W., Haberg, S. E., Wu, M. C., Nilsen, R. M., … Motsinger-Reif, A. (2016). Maternal smoking impacts key biological pathways in newborns through epigenetic modification in Utero. BMC Genomics, 17.

Rotroff, D. M., Corum, D. G., Motsinger-Reif, A., Fiehn, O., Bottrel, N., Drevets, W. C., … Kaddurah-Daouk, R. (2016). Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: New mechanistic insights for rapid acting antidepressants. Translational Psychiatry, 6.

Rotroff, D. M., Oki, N. O., Liang, X. M., Yee, S. W., Stocker, S. L., Corum, D. G., … Kaddurah-Daouk, R. (2016). Pharmacometabolomic assessment of metformin in non-diabetic, African Americans. Frontiers in Pharmacology, 7.

Zhou, K. X., Yee, S. W., Seiser, E. L., Leeuwen, N., Tavendalel, R., Bennett, A. J., … Chen, L. (2016). Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin. Nature Genetics, 48(9), 1055-.

Roode, S. C., Rotroff, D., Avery, A. C., Suter, S. E., Bienzle, D., Schiffman, J. D., … Breen, M. (2015). Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation. Chromosome Research, 23(4), 681–708. https://doi.org/10.1007/s10577-015-9475-7

Judson, R. S., Magpantay, F. M., Chickarmane, V., Haskell, C., Tania, N., Taylor, J., … Knudsen, T. B. (2015). Integrated model of chemical perturbations of a biological pathway using 18 in vitro high-throughput screening assays for the estrogen receptor. Toxicological Sciences, 148(1), 137–154.

Thomas, R., Borst, L., Rotroff, D., Motsinger-Reif, A., Lindblad-Toh, K., Modiano, J. F., & Breen, M. (2014). Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma. CHROMOSOME RESEARCH, 22(3), 305–319. https://doi.org/10.1007/s10577-014-9406-z

Jack, J., Rotroff, D., & Motsinger-Reif, A. (2014). Lymphoblastoid Cell Lines Models of Drug Response: Successes and Lessons from this Pharmacogenomic Model. CURRENT MOLECULAR MEDICINE, 14(7), 833–840. https://doi.org/10.2174/1566524014666140811113946

Rotroff, D., Jack, J., Campbell, N., Clark, S., & Motsinger-Reif, A. A. (2014). PGxClean: a quality control GUI for the Affymetrix DMET chip and other candidate gene studies with non-biallelic alleles. Biodata Mining, 7.

Zang, Q., Rotroff, D. M., & Judson, R. S. (2013). Binary Classification of a Large Collection of Environmental Chemicals from Estrogen Receptor Assays by Quantitative Structure-Activity Relationship and Machine Learning Methods. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 53(12), 3244–3261. https://doi.org/10.1021/ci400527b

Rotroff, D. M., Thomas, R., Breen, M., & Motsinger-Reif, A. A. (2013, December). Naturally occuring canine cancers: powerful models for stimulating pharmacogenomic advancement in human medicine. PHARMACOGENOMICS, Vol. 14, pp. 1929–1931. https://doi.org/10.2217/pgs.13.178